PriceTargets.com logo

Alkami Technology - ALKT Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $26.67
  • Forecasted Upside: 57.51%
  • Number of Analysts: 8
  • Breakdown:
  • 1 Sell Ratings
  • 3 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$16.93 As of 03/19/2026 05:00 PM ET
▼ -0.48 (-2.76%)

This chart shows the closing price for ALKT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Alkami Technology Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ALKT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ALKT

Analyst Price Target is $26.67
▲ +57.51% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Alkami Technology in the last 3 months. The average price target is $26.67, with a high forecast of $41.00 and a low forecast of $21.00. The average price target represents a 57.51% upside from the last price of $16.93.

This chart shows the closing price for ALKT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 8 investment analysts is to hold stock in Alkami Technology. This rating has held steady since October 2025, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
9/25/2024
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/24/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
3/24/2025
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/22/2025
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/20/2025
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
12/19/2025
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
2/17/2026
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
3/19/2026

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/26/2026Needham & Company LLCLower TargetBuy ➝ Buy$32.00 ➝ $22.00
2/26/2026BarclaysLower TargetEqual Weight ➝ Equal Weight$25.00 ➝ $21.00
2/26/2026Citizens JmpLower TargetMarket Outperform ➝ Market Outperform$40.00 ➝ $28.00
2/18/2026JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$38.00 ➝ $22.00
1/29/2026Citizens JmpReiterated RatingMarket Outperform ➝ Market Outperform$40.00
1/21/2026Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
11/4/2025Zacks ResearchDowngradeStrong-Buy ➝ Hold
10/31/2025The Goldman Sachs GroupLower TargetNeutral ➝ Neutral$29.00 ➝ $26.00
10/31/2025JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$40.00 ➝ $38.00
10/31/2025BarclaysLower TargetEqual Weight ➝ Equal Weight$30.00 ➝ $25.00
10/31/2025Citizens JmpLower TargetMarket Outperform ➝ Market Outperform$46.00 ➝ $40.00
10/31/2025Needham & Company LLCLower TargetBuy ➝ Buy$40.00 ➝ $32.00
10/8/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
9/27/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
6/18/2025JPMorgan Chase & Co.Initiated CoverageOverweight$45.00 ➝ $40.00
5/1/2025Lake Street CapitalLower TargetBuy ➝ Buy$47.00 ➝ $41.00
5/1/2025Citizens JmpReiterated RatingMarket Outperform ➝ Market Outperform$46.00 ➝ $46.00
5/1/2025Needham & Company LLCLower TargetBuy ➝ Buy$54.00 ➝ $40.00
4/14/2025BarclaysLower TargetEqual Weight ➝ Equal Weight$35.00 ➝ $30.00
3/13/2025StephensUpgradeEqual Weight ➝ Overweight$40.00
3/3/2025The Goldman Sachs GroupLower TargetNeutral ➝ Neutral$39.00 ➝ $32.00
3/3/2025BarclaysLower TargetEqual Weight ➝ Equal Weight$41.00 ➝ $35.00
12/9/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$42.00 ➝ $45.00
11/1/2024The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$34.00 ➝ $39.00
10/31/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$35.00 ➝ $41.00
10/31/2024Craig HallumBoost TargetBuy ➝ Buy$38.00 ➝ $45.00
10/31/2024Needham & Company LLCBoost TargetBuy ➝ Buy$43.00 ➝ $54.00
10/29/2024Citizens JmpBoost TargetMarket Outperform ➝ Market Outperform$38.00 ➝ $41.00
8/1/2024Needham & Company LLCBoost TargetBuy ➝ Buy$32.00 ➝ $43.00
8/1/2024Citizens JmpBoost TargetMarket Outperform ➝ Market Outperform$35.00 ➝ $38.00
8/1/2024Lake Street CapitalBoost TargetBuy ➝ Buy$30.00 ➝ $36.00
8/1/2024Craig HallumBoost TargetBuy ➝ Buy$31.00 ➝ $38.00
8/1/2024The Goldman Sachs GroupBoost TargetNeutral ➝ Neutral$28.00 ➝ $34.00
8/1/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$31.00 ➝ $35.00
7/22/2024Citizens JmpBoost TargetMarket Outperform ➝ Market Outperform$30.00 ➝ $35.00
7/11/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$28.00 ➝ $31.00
6/25/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$32.00 ➝ $32.00
5/2/2024Craig HallumBoost TargetBuy ➝ Buy$30.00 ➝ $31.00
5/2/2024Needham & Company LLCBoost TargetBuy ➝ Buy$30.00 ➝ $32.00
4/15/2024Citizens JmpReiterated RatingMarket Outperform ➝ Market Outperform$30.00
2/29/2024Citizens JmpBoost TargetMarket Outperform ➝ Market Outperform$25.00 ➝ $30.00
2/29/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$27.00 ➝ $31.00
2/29/2024William BlairReiterated RatingOutperform
2/29/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$30.00
2/29/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$26.00 ➝ $27.00
1/23/2024The Goldman Sachs GroupDowngradeBuy ➝ Neutral$23.00 ➝ $27.00
1/8/2024KeyCorpBoost TargetOverweight ➝ Overweight$21.00 ➝ $26.00
1/5/2024Needham & Company LLCBoost TargetBuy ➝ Buy$24.00 ➝ $30.00
1/4/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$22.00 ➝ $26.00
12/7/2023StephensDowngradeOverweight ➝ Equal Weight$22.00 ➝ $24.00
11/3/2023Citizens JmpBoost TargetMarket Outperform ➝ Market Outperform$23.00 ➝ $25.00
11/2/2023Needham & Company LLCBoost TargetBuy ➝ Buy$21.00 ➝ $24.00
11/2/2023JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$19.00 ➝ $21.00
11/2/2023William BlairReiterated RatingOutperform
8/10/2023CitigroupBoost TargetBuy ➝ Buy$19.00 ➝ $20.00
8/4/2023KeyCorpBoost TargetOverweight ➝ Overweight$15.00 ➝ $19.00
8/3/2023Needham & Company LLCBoost TargetBuy ➝ Buy$20.00 ➝ $21.00
8/3/2023BarclaysBoost TargetEqual Weight ➝ Equal Weight$18.00 ➝ $19.00
7/14/2023BarclaysBoost TargetEqual Weight$14.00 ➝ $18.00
7/12/2023The Goldman Sachs GroupInitiated CoverageBuy$21.00
6/27/2023Lake Street CapitalInitiated CoverageBuy$21.00
6/8/2023Craig HallumInitiated CoverageBuy$25.00
5/9/2023JPMorgan Chase & Co.Initiated CoverageOverweight$15.00
5/4/2023500.comReiterated RatingReiterates
4/13/2023BarclaysLower TargetEqual Weight$17.00 ➝ $14.00
3/23/2023KeyCorpLower TargetOverweight$18.00 ➝ $15.00
2/24/2023Needham & Company LLCReiterated RatingBuy$20.00
2/24/2023CitigroupBoost TargetBuy$18.00 ➝ $22.00
1/20/2023KeyCorpBoost TargetOverweight$16.00 ➝ $18.00
9/14/2022StephensInitiated CoverageOverweight$18.00
8/4/2022Needham & Company LLCBoost TargetBuy$17.00 ➝ $20.00
8/4/2022BarclaysBoost TargetEqual Weight$15.00 ➝ $16.00
7/7/2022KeyCorpLower TargetOverweight$20.00 ➝ $18.00
6/21/2022CitigroupLower TargetBuy$32.00 ➝ $18.00
5/9/2022BarclaysLower Target$17.00 ➝ $15.00
2/24/2022Needham & Company LLCLower TargetBuy$40.00 ➝ $22.00
1/25/2022KeyCorpLower TargetOverweight$35.00 ➝ $20.00
1/19/2022BarclaysLower TargetEqual Weight$33.00 ➝ $19.00
12/14/2021JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$62.00 ➝ $40.00
11/8/2021KeyCorpLower TargetOverweight$50.00 ➝ $35.00
11/5/2021Needham & Company LLCLower TargetBuy$50.00 ➝ $40.00
10/13/2021BarclaysLower TargetEqual Weight$40.00 ➝ $33.00
7/15/2021BarclaysLower TargetEqual Weight$47.00 ➝ $40.00
5/10/2021William BlairInitiated CoverageOutperform
5/10/2021UBS GroupInitiated CoverageBuy$50.00
5/10/2021BarclaysInitiated CoverageEqual Weight$47.00
5/10/2021KeyCorpInitiated CoverageOverweight$50.00
5/10/2021Needham & Company LLCInitiated CoverageBuy$50.00
5/10/2021Citizens JmpInitiated CoverageOutperform$50.00
5/10/2021The Goldman Sachs GroupInitiated CoverageNeutral$42.00
(Data available from 3/19/2021 forward)

News Sentiment Rating

0.77 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 14 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/21/2025
  • 2 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/20/2025
  • 1 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/20/2025
  • 6 very positive mentions
  • 18 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/19/2025
  • 2 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/19/2025
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/18/2026
  • 0 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/17/2026
  • 32 very positive mentions
  • 28 positive mentions
  • 4 negative mentions
  • 3 very negative mentions
Mentions as of
3/19/2026

Current Sentiment

  • 32 very positive mentions
  • 28 positive mentions
  • 4 negative mentions
  • 3 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Alkami Technology logo
Alkami Technology, Inc. offers cloud-based digital banking solutions in the United States. The company's Alkami Platform allows financial institutions to onboard and engage new users, accelerate revenues, and enhance operational efficiency, with the support of a proprietary, cloud-based, and multi-tenant architecture. It serves community, regional, super-regional credit unions, and banks. The company was founded in 2009 and is headquartered in Plano, Texas.
Read More

Today's Range

Now: $16.93
Low: $16.66
High: $17.98

50 Day Range

MA: $18.43
Low: $15.48
High: $22.41

52 Week Range

Now: $16.93
Low: $14.11
High: $31.66

Volume

1,451,182 shs

Average Volume

2,139,028 shs

Market Capitalization

$1.80 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.57

Frequently Asked Questions

What sell-side analysts currently cover shares of Alkami Technology?

The following Wall Street research analysts have issued research reports on Alkami Technology in the last year: Barclays PLC, Citizens Jmp, JPMorgan Chase & Co., Lake Street Capital, Needham & Company LLC, The Goldman Sachs Group, Inc., Weiss Ratings, and Zacks Research.
View the latest analyst ratings for ALKT.

What is the current price target for Alkami Technology?

0 Wall Street analysts have set twelve-month price targets for Alkami Technology in the last year. Their average twelve-month price target is $26.67, suggesting a possible upside of 57.5%. Lake Street Capital has the highest price target set, predicting ALKT will reach $41.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $21.00 for Alkami Technology in the next year.
View the latest price targets for ALKT.

What is the current consensus analyst rating for Alkami Technology?

Alkami Technology currently has 1 sell rating, 3 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ALKT, but not buy more shares or sell existing shares.
View the latest ratings for ALKT.

What other companies compete with Alkami Technology?

Other companies that are similar to Alkami Technology include Q2, NiCE, Match Group, Clearwater Analytics and Paycom Software. Learn More about companies similar to Alkami Technology.

How do I contact Alkami Technology's investor relations team?

The company's listed phone number is 877-725-5264 and its investor relations email address is [email protected]. The official website for Alkami Technology is www.alkami.com. Learn More about contacing Alkami Technology investor relations.